Syed Ali-aamir Rizvi - 21 Feb 2023 Form 4 Insider Report for Caribou Biosciences, Inc. (CRBU)

Role
Chief Medical Officer
Signature
/s/ Barbara G. McClung, as attorney-in-fact
Issuer symbol
CRBU
Transactions as of
21 Feb 2023
Transactions value $
$0
Form type
4
Date filed
23 Feb 2023, 16:09
Previous filing
20 Jan 2023
Next filing
03 Apr 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRBU Option to purchase Common Stock Award $0 +131K $0.00 131K 21 Feb 2023 Common Stock 131K $6.12 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option will vest in equal monthly installments starting on the first monthly anniversary of the grant date until the option is fully vested on February 21, 2027, subject to the reporting person's continued service to the Issuer through the applicable vesting dates.